JPH11170A5 - - Google Patents
Info
- Publication number
- JPH11170A5 JPH11170A5 JP1997057503A JP5750397A JPH11170A5 JP H11170 A5 JPH11170 A5 JP H11170A5 JP 1997057503 A JP1997057503 A JP 1997057503A JP 5750397 A JP5750397 A JP 5750397A JP H11170 A5 JPH11170 A5 JP H11170A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- polypeptide
- acid sequence
- seq
- nucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1328596P | 1996-03-12 | 1996-03-12 | |
| US2871196P | 1996-10-17 | 1996-10-17 | |
| US3734197P | 1997-02-06 | 1997-02-06 | |
| US60/013285 | 1997-02-06 | ||
| US60/037341 | 1997-02-06 | ||
| US60/028711 | 1997-02-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH11170A JPH11170A (ja) | 1999-01-06 |
| JPH11170A5 true JPH11170A5 (enExample) | 2005-02-10 |
Family
ID=27359824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9057503A Pending JPH11170A (ja) | 1996-03-12 | 1997-03-12 | デスドメイン含有受容体 |
Country Status (3)
| Country | Link |
|---|---|
| US (3) | US6153402A (enExample) |
| JP (1) | JPH11170A (enExample) |
| WO (1) | WO1997033904A1 (enExample) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7597886B2 (en) | 1994-11-07 | 2009-10-06 | Human Genome Sciences, Inc. | Tumor necrosis factor-gamma |
| US20030198640A1 (en) * | 1994-11-07 | 2003-10-23 | Human Genome Sciences, Inc. | Methods and compositions for treating inflammatory bowel diseases relating to human tumor necrosis factor-gamma-beta |
| US7429646B1 (en) | 1995-06-05 | 2008-09-30 | Human Genome Sciences, Inc. | Antibodies to human tumor necrosis factor receptor-like 2 |
| US7888466B2 (en) | 1996-01-11 | 2011-02-15 | Human Genome Sciences, Inc. | Human G-protein chemokine receptor HSATU68 |
| WO1997033904A1 (en) | 1996-03-12 | 1997-09-18 | Human Genome Sciences, Inc. | Death domain containing receptors |
| US6713061B1 (en) | 1996-03-12 | 2004-03-30 | Human Genome Sciences, Inc. | Death domain containing receptors |
| US7964190B2 (en) | 1996-03-22 | 2011-06-21 | Human Genome Sciences, Inc. | Methods and compositions for decreasing T-cell activity |
| US6635743B1 (en) | 1996-03-22 | 2003-10-21 | Human Genome Sciences, Inc. | Apoptosis inducing molecule II and methods of use |
| US20020165157A1 (en) * | 1996-04-01 | 2002-11-07 | Genentech, Inc. | Apo-2LI and Apo-3 polypeptides |
| WO1997037020A1 (en) * | 1996-04-01 | 1997-10-09 | Genentech, Inc. | Apo-2li and apo-3 apoptosis polypeptides |
| US6462176B1 (en) * | 1996-09-23 | 2002-10-08 | Genentech, Inc. | Apo-3 polypeptide |
| EP0960196A4 (en) * | 1996-10-04 | 2002-10-29 | Immunex Corp | CELL DEATH CAUSING RECEPTOR |
| US6297022B1 (en) | 1997-10-08 | 2001-10-02 | Smithkline Beecham Corporation | Method of identifying agonists and antagonists for tumor necrosis related receptor TR1 |
| EP1054961A2 (en) * | 1998-02-17 | 2000-11-29 | Incyte Pharmaceuticals, Inc. | Human short-chain tnf-receptor family protein |
| US20030078211A1 (en) * | 1998-06-24 | 2003-04-24 | Merck & Co., Inc. | Compositions and methods for inhibiting bone resorption |
| JP2002537769A (ja) | 1999-02-26 | 2002-11-12 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | ヒトエンドカインαおよび使用方法 |
| CA2371114A1 (en) * | 1999-04-22 | 2000-11-02 | Human Genome Sciences, Inc. | Death domain containing receptors |
| WO2001016180A2 (en) * | 1999-08-27 | 2001-03-08 | Board Of Regents, The University Of Texas System | Cd40 agonist compositions and methods of use |
| US6994976B1 (en) | 1999-11-19 | 2006-02-07 | Tittle Thomas V | Tr3-specific binding agents and methods for their use |
| MXPA02005069A (es) * | 1999-11-19 | 2003-09-25 | Wegmann Keith W | Agentes de enlace especificos para t3 y metodos para su uso. |
| CA2405550A1 (en) | 2000-04-12 | 2001-10-25 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| WO2001096528A2 (en) | 2000-06-15 | 2001-12-20 | Human Genome Sciences, Inc. | Human tumor necrosis factor delta and epsilon |
| EP2275449B1 (en) | 2000-06-16 | 2016-09-28 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to BLyS |
| JP3898126B2 (ja) * | 2000-10-24 | 2007-03-28 | 俊一 塩澤 | 慢性関節リウマチに関与するゲノム、その診断方法、その発症可能性の判定方法、それらの検出用診断キットおよび、慢性関節リウマチの治療方法ならびに治療薬剤 |
| US6965023B2 (en) * | 2000-11-17 | 2005-11-15 | The Burnham Institute | Death domain proteins |
| AU2002364586A1 (en) | 2001-12-21 | 2003-07-30 | Delta Biotechnology Limited | Albumin fusion proteins |
| CA2536086C (en) * | 2003-08-20 | 2013-03-19 | University Of Miami | Inhibition of dr3 in the treatment of allergic lung inflammation |
| CA2621083C (en) | 2005-08-30 | 2017-04-11 | University Of Miami | Immunomodulating tumor necrosis factor receptor 25 (tnfr25) agonists, antagonists and immunotoxins |
| EA015860B1 (ru) | 2005-10-13 | 2011-12-30 | Хьюман Дженом Сайенсиз, Инк. | Способы лечения аутоиммунных заболеваний при использовании антагониста нейтрокина-альфа |
| US9896511B2 (en) | 2007-01-10 | 2018-02-20 | The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services | Antibodies that bind to TL1A and methods of treating inflammatory or autoimmune disease comprising administering such antibodies |
| WO2010036986A2 (en) | 2008-09-26 | 2010-04-01 | Tocagen Inc. | Recombinant vectors |
| JP2013501057A (ja) | 2009-08-03 | 2013-01-10 | ユニバーシティー・オブ・マイアミ | 制御性ｔ細胞のｉｎｖｉｖｏにおける増殖 |
| AR084141A1 (es) | 2010-11-19 | 2013-04-24 | Imai Toshio | Anticuerpos neutralizadores anti-ccl20 |
| CA2828464A1 (en) | 2011-03-01 | 2012-09-07 | Novo Nordisk A/S | Antagonistic dr3 ligands |
| WO2012161856A1 (en) * | 2011-05-20 | 2012-11-29 | Government Of The United States, As Represented By The Secretary, Department Of Health And Human Services | Blockade of tl1a-dr3 interactions to ameliorate t cell mediated disease pathology and antibodies thereof |
| EP2909324B1 (en) | 2012-10-25 | 2020-02-26 | Tocagen Inc. | Retroviral vector with mini-promoter cassette |
| US20140193410A1 (en) | 2013-01-09 | 2014-07-10 | University Of Miami | Compositions and Methods for the Regulation of T Regulatory Cells Using TL1A-Ig Fusion Protein |
| ES2644022T3 (es) | 2013-03-14 | 2017-11-27 | Bristol-Myers Squibb Company | Combinación de un agonista de DR5 y un antagonista de anti-PD-1 y métodos de uso |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| CA1295562C (en) * | 1982-07-30 | 1992-02-11 | Bernard Francois Mach | DNA SEQUENCES CODING FOR THE DR.beta.-CHAIN LOCUS OF THE HUMAN LYMPHOCYTE ANTIGEN COMPLEX AND POLYPEPTIDES, DIAGNOSTIC TYPING PROCESSES AND PRODUCTS RELATED THERETO |
| US5120525A (en) | 1988-03-29 | 1992-06-09 | Immunomedics, Inc. | Radiolabeled antibody cytotoxic therapy of cancer |
| US5349052A (en) | 1988-10-20 | 1994-09-20 | Royal Free Hospital School Of Medicine | Process for fractionating polyethylene glycol (PEG)-protein adducts and an adduct for PEG and granulocyte-macrophage colony stimulating factor |
| EP0401384B1 (en) | 1988-12-22 | 1996-03-13 | Kirin-Amgen, Inc. | Chemically modified granulocyte colony stimulating factor |
| IL106271A (en) * | 1992-09-03 | 2008-03-20 | Yeda Res & Dev | Ligand to TNF 75P receptor and its preparation |
| US5395760A (en) * | 1989-09-05 | 1995-03-07 | Immunex Corporation | DNA encoding tumor necrosis factor-α and -β receptors |
| US5464938A (en) * | 1990-04-09 | 1995-11-07 | Immunex Corporation | Isolated viral protein TNF antagonists |
| AU692146B2 (en) * | 1990-06-27 | 1998-06-04 | Biogen Idec Ma Inc. | Lymphotoxin-beta, lymphotoxin-beta complexes, pharmaceutical preparations and therapeutic uses thereof |
| US5656272A (en) | 1991-03-18 | 1997-08-12 | New York University Medical Center | Methods of treating TNF-α-mediated Crohn's disease using chimeric anti-TNF antibodies |
| EP0506477B1 (en) | 1991-03-28 | 1999-06-23 | Merck & Co. Inc. | Vascular endothelial cell growth factor C subunit |
| IL99120A0 (en) | 1991-08-07 | 1992-07-15 | Yeda Res & Dev | Multimers of the soluble forms of tnf receptors,their preparation and pharmaceutical compositions containing them |
| WO1994009137A1 (en) * | 1992-10-15 | 1994-04-28 | Genentech, Inc. | Antibodies against type 2 tumor necrosis factor receptor |
| GB9317618D0 (en) | 1993-08-24 | 1993-10-06 | Royal Free Hosp School Med | Polymer modifications |
| NZ275711A (en) | 1993-10-14 | 1998-03-25 | Immunex Corp | Monoclonal antibodies and binding proteins which bind to human fas antigen (nerve growth factor/tumour necrosis factor receptor type) |
| US5643575A (en) | 1993-10-27 | 1997-07-01 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
| US6608182B1 (en) | 1994-03-08 | 2003-08-19 | Human Genome Sciences, Inc. | Human vascular endothelial growth factor 2 |
| AU708972B2 (en) | 1994-11-07 | 1999-08-19 | Human Genome Sciences, Inc. | Tumor necrosis factor-gamma |
| US6599719B2 (en) | 1994-11-07 | 2003-07-29 | Human Genome Sciences, Inc. | Nucleic acid molecules encoding tumor necrosis factor-gamma-alpha |
| US5928939A (en) | 1995-03-01 | 1999-07-27 | Ludwig Institute For Cancer Research | Vascular endothelial growth factor-b and dna coding therefor |
| JPH11507205A (ja) | 1995-04-27 | 1999-06-29 | ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド | ヒト腫瘍壊死因子受容体 |
| WO1997033904A1 (en) | 1996-03-12 | 1997-09-18 | Human Genome Sciences, Inc. | Death domain containing receptors |
| WO1997033899A1 (en) | 1996-03-14 | 1997-09-18 | Human Genome Sciences, Inc. | Apoptosis inducing molecule i |
| EP0904278A4 (en) | 1996-03-22 | 1999-09-15 | Human Genome Sciences Inc | MOLECULE II INDUCER OF APOPTOSIS |
| WO1997037020A1 (en) * | 1996-04-01 | 1997-10-09 | Genentech, Inc. | Apo-2li and apo-3 apoptosis polypeptides |
| CA2260754C (en) | 1996-07-15 | 2012-01-24 | Chugai Research Institute For Molecular Medicine, Inc. | Novel vegf-like factor |
| ATE294863T1 (de) | 1996-07-15 | 2005-05-15 | Chugai Pharmaceutical Co Ltd | Neuartige vegf-ähnliche faktoren |
| WO1998006842A1 (en) | 1996-08-16 | 1998-02-19 | Schering Corporation | Mammalian cell surface antigens; related reagents |
| ES2316153T3 (es) | 1996-08-16 | 2009-04-01 | Human Genome Sciences, Inc. | Endoquina alfa humana. |
| EP1749836B1 (en) | 1996-08-23 | 2009-06-17 | Vegenics Limited | Recombinant vascular endothelial cell growth factor D (VEGF-D) |
| EP0960196A4 (en) * | 1996-10-04 | 2002-10-29 | Immunex Corp | CELL DEATH CAUSING RECEPTOR |
| BR9612752A (pt) | 1996-10-25 | 2000-01-18 | Human Genome Sciences Inc | Neutrocina |
| CA2277925A1 (en) | 1997-01-14 | 1998-07-16 | Human Genome Sciences, Inc. | Tumor necrosis factor receptors 6.alpha. and 6.beta. |
| ATE321855T1 (de) | 1997-01-14 | 2006-04-15 | Human Genome Sciences Inc | Tumor-nekrose-faktor rezeptor 5 |
| ATE362982T1 (de) | 1997-01-28 | 2007-06-15 | Human Genome Sciences Inc | ßDEATH-DOMAINß-ENTHALTENDER REZEPTOR 4 (DR4), EIN MITGLIED DER TNF-REZEPTOR SUPERFAMILIE, WELCHER AN TRAIL (APO-2L) BINDET |
| EP0921817B1 (en) | 1997-01-29 | 2001-03-28 | PolyMASC Pharmaceuticals plc | Pegylation process |
| NZ337795A (en) | 1997-03-17 | 2001-06-29 | Human Genome Sciences Inc | Death domain containing receptor 5 and it's use in the treatment of DR5 related disease |
| CA2288351A1 (en) | 1997-05-01 | 1998-11-05 | Amgen Inc. | Chimeric opg polypeptides |
| WO1998056892A1 (en) | 1997-06-11 | 1998-12-17 | Human Genome Sciences, Inc. | Human tumor necrosis factor receptor tr9 |
-
1996
- 1996-10-17 WO PCT/US1996/016849 patent/WO1997033904A1/en not_active Ceased
-
1997
- 1997-03-11 US US08/815,469 patent/US6153402A/en not_active Expired - Fee Related
- 1997-03-12 JP JP9057503A patent/JPH11170A/ja active Pending
-
1999
- 1999-05-19 US US09/314,889 patent/US6951735B2/en not_active Expired - Lifetime
- 1999-06-16 US US09/333,966 patent/US6759513B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH11170A5 (enExample) | ||
| JP2002502589A5 (enExample) | ||
| JP2001520513A (ja) | 死ドメイン含有レセプター５ | |
| KR960704038A (ko) | 세포 표면 수용체 Hek와 결합하는 사이토킨(Cytokines That Bind the Cell Surface Receptor Hek) | |
| CA2343655A1 (en) | Interleukin 17-like receptor protein | |
| JP2005521429A5 (enExample) | ||
| CA2443617A1 (en) | Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions | |
| JP2002522041A5 (enExample) | ||
| JP2002503963A (ja) | ヒト腫瘍壊死因子受容体ｔｒ９ | |
| JP2002521055A5 (enExample) | ||
| JP2005514901A5 (enExample) | ||
| JP2002516103A5 (enExample) | ||
| JP2002518010A5 (enExample) | ||
| JP2002500043A5 (enExample) | ||
| JP2005518212A5 (enExample) | ||
| JP2002533122A (ja) | Ｉｌ−１関連ポリペプチド | |
| WO2002006334A1 (fr) | Nouveau polypeptide, proteine humaine de grande taille 10.01, et polynucleotide codant ce polypeptide | |
| WO2002006475A1 (en) | A NOVEL POLYPEPTIDE, A PREGNANCY SPECIFIC β 1-GLUCOPROTEIN 9.02 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE | |
| WO2002040525A1 (fr) | Nouveau polypeptide, proteine humaine a doigt de zinc 18.92, et polynucleotide codant ce polypeptide | |
| WO2002048355A1 (fr) | Nouveau polypeptide, proteine garp humaine 12.98, et polynucleotide codant ce polypeptide | |
| WO2001092319A1 (fr) | NOUVEAU POLYPEPTIDE, RECEPTEUR HUMAIN 19.68 DE L'INTERFERON α, ET POLYNUCLEOTIDE CODANT CE POLYPEPTIDE | |
| WO2002004634A1 (fr) | Nouveau polypeptide, proteine humaine d'apoptose 9.46, et polynucleotide codant ce polypeptide | |
| WO2002014510A1 (fr) | Nouveau polypeptide, proteine cbp20 humaine 47.74, et polynucleotide codant ce polypeptide | |
| WO2002020580A1 (fr) | Nouveau polypeptide, proteine humaine 15 tnfr/ngfr contenant un domaine de cytochrome c, et polynucleotide codant ce polypeptide | |
| WO2001090177A1 (fr) | Nouveau polypeptide, activateur humain de la mort naturelle des cellules b13.64, et polynucleotide codant ce polypeptide |